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Abstract 
Osteogenesis imperfecta (OI) is a skeletal 
dyscrasia characterized by decreased bone 
strength and associated fractures.  Over 95% of 
autosomal dominant forms of this disease are 
associated with defects in the genes for collagen 
COL1A1 and COL1A2.1  The lethal type II 
disease has been identified antenatally by 
symmetrically shortened long bones and 
micromelia.  Many reports have indicated that a 
femur length to abdominal circumference ratio 
(FL:AC) of less than 0.16 is predictive of lethality 
associated  with OI.2,3  We report a case that 
presented at 20 weeks’ gestation with 
shortening of the lower limbs, specifically a 
lagging femur length and FL:AC of < 0.16. On 
subsequent ultrasound examinations, 
progressive shortening of the femur as well as 
shortening of the long bones of the upper 
extremities was documented. The thorax 
appeared normal until 31 weeks. The FL:AC 
remained below 0.16 throughout pregnancy.   
Workup in the neonatal period identified a novel 
mutation in COL1A1.  The neonate was able to 
breathe spontaneously at birth requiring minimal 
respiratory support for the initial 2 weeks and 
lived for 26 days. 
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Introduction 
Osteogenesis imperfecta (OI) is a 
heterogenous inheritable bone disease 
characterized by defects in bone matrix 
formation, which results in decreased 
bone strength and leads to bone 
fragility, deformity and short stature. 
About 95% of all cases of OI are 
classified into 4 subtypes (I-IV) first 
described by Sillence et al4 and are 
associated with mutations that affect 
type I collagen genes, COL1A1 and 
COL1A2.1 Of the four main types of OI, 
type II is considered lethal with type III 
being severe.  Both type II and type III 
OI are caused by dominant structural 
mutations in COL1A1 and COL1A2 
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which result in abnormal formation of 
collagen polymers and bone matrix 
disruption.1 Overall, OI affects one in 
10,000 live births in the United States 
with the lethal type II phenotype making 
up 10% of these cases.1 
Early prenatal diagnosis is critical to 
appropriately counsel patients on 
pregnancy options including pregnancy 
termination and in continuing 
pregnancies, the delivery strategies 
including whether or not a cesarean 
section would be advisable based on 
predicted survival. Previous reports 
have shown that ultrasonography can 
identify between 63 and 89% of OI 
antenatally.5 Findings during prenatal 
ultrasound include micromelia and bone 
demineralization as early as 14 weeks 
for type II disease in addition to shorted 
long bones (<5th percentile) associated 
with skeletal dyscrasia in general.6 The 
ratio of femur length to abdominal 
circumference has been previously 
shown to distinguish lethal skeletal 
dyscrasia including OI.2,3 One report 
notes that the mean age for diagnosing 
lethal skeletal dyscrasias based on 
FL:AC was 20.4 weeks, suggesting that 
this ratio may be used in antenatal 
counseling regarding options for 
termination; however, the specific 
diagnosis was only correct 65% of the 
time.7 
Case Report 
A 26 yo G1P0 woman was referred at 
19 weeks gestational age (GA) due to 
abnormally shortened femurs noted on a 
local ultrasound examination (US). 
Antenatal integrated serum screening 
test was negative. Her family history 
was not contributory. On ultrasound 
examination, we confirmed the findings 
of shortened femur length (FL) of 18.2 
mm, which was <3rd percentile. Nasal 
bone measured 4.6 mm, at the 2.5th 
percentile. Most of the other long bone 
measurements were lagging but still 
within the normal range for the 
gestational age (Table 1).  
 
Table 1. Ultrasound findings: The measurements expressed in percentiles at the 
three ultrasound examinations performed at 190, 230 and 31 4/7 gestational weeks.  
Gestational Age (weeks) 190 230 314 
Estimated fetal weight in grams (percentile) 218 396 (14) 1024  (<10) 
Biparietal diameter  in mm (percentile) 46.8 (80) 52.5 (23) 85.3 (94) 
Head Circumference in mm (percentile) 159.6 (30) 198.7 (8) 288.7 (29) 
Femur length in mm (percentile) 18.2 (<3) 26.5 (<3) 31.2 (<3) 
FL:AC Ratio 0.13 0.15 0.12 
Thoracic circumference in mm (percentile) 114 (41) 142 (25) 194 (5) 
Abdominal circumference in mm (percentile) 132.4 (33) 174.4 (22) 254.7 (11) 
Humerus length in mm (percentile) 23.9 (5) 30.2 (<5) 41 (<5) 
Radius length in mm (percentile) 20.2 (5) 25.3 (5) 24 (<5) 
Ulna in mm (percentile) 24.0 (32) 30.4 (<5) 40.4 (<5) 
Tibia in mm (percentile) 18.2 (<5) 23.2 (<5) Not measured 
Fibula in mm (percentile) 19.2 (<5) 20.6 (<5) Not measured 
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The biparietal diameter (BPD), 
abdominal circumference (AC) and 
thoracic circumference (TC) measured 
normal for the gestational age. Both feet 
were at the 5th percentile. There was no 
evidence of fractures. Nuchal skin fold 
measured normal at 4.5 mm. 
The differential diagnosis included 
thanatophoric dwarfism, OI, and 
achondrogenesis. The patient was 
counseled that the findings were 
consistent with skeletal dysplasia. In 
view of the FL:AC ratio of 0.13, this 
skeletal dysplasia would likely be lethal 
in the neonatal period. The patient was 
presented with options for antenatal 
genetic testing, expectant management 
as well as pregnancy termination. She 
desired expectant management and 
returned at 23 weeks for a follow up 
examination. At the repeat exam, the FL 
measured 26.5mm (<5th percentile), FL: 
AC ratio was 0.15. The thorax measured 
at the 25th percentile and the AC was at 
the 22nd percentile. At 31 weeks and 4 
days the FL:AC ratio continued to be 
abnormal at 0.12, and the chest 
circumference at this examination was < 
5th percentile. The fetal skull appeared 
to have decreased mineralization, and 
the contour was easily distorted with 
light pressure applied on the fetal head 
via maternal abdomen with the 
transducer (Figure 1). For the first time, 
the ribs appeared flattened and shorter, 
but there were no obvious fractures in 
any of the long bones.   
The patient experienced preterm-
premature rupture of membranes at 33 
weeks and 5 days. She received 
steroids for fetal lung maturation as well 
as ampicillin and azithromycin 
prophylaxis. At 34 weeks the patient 
went into spontaneous labor which was 
augmented with oxytocin. In view of the 
abnormal FL:AC ratio and high 
probability of neonatal death, fetal heart 
rate was monitored intermittently with 
plans for a vaginal delivery. A 1528 
gram male infant was born with Apgar 
scores of 4, 6 and 6 at 1, 5 and 10 
minutes respectively. The infant was 
born with spontaneous respirations. 
Multiple acute and healing fractures 
were noted on skeletal survey, 
suggesting OI. Genetic analysis showed 
a novel mutation in the COL1A1 gene 
c1363G>A in exon 21 of chromosome 
17 resulting in a missense mutation of 
Gly 455 Ser. Testing for FGFR3 gene 
was negative for thanatophoric 
dysplasia. In the NICU, the baby was 
reported to have a good cry and mild 
respiratory distress requiring 21% 
oxygen by nasal cannula. Starting age 2 
weeks, the oxygen requirement 
gradually increased with a FiO2 of 25-
30%. On day of life 19, apneic episodes 
increased and respiratory failure 
worsened requiring 100% oxygen by 
cannula. The parents expressed their 
wishes to not pursue more aggressive 
life support measures, and the neonate 
died at age 26 days. 
Discussion 
OI is a skeletal dyscrasia that has both 
autosomal dominant and recessive 
modes of inheritance. Here, we describe 
a novel mutation of COL1A1 gene that 
was associated with lethal OI type II. It 
also highlights that isolated findings of 
early onset shortened femur bones with 
a decreased FL:AC ratio can be critical 
components of antenatal counseling of 
the lethality of the condition and timely 
pregnancy management options.
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Figure 1. At 31 4/7 weeks gestation the fetal skull was easily compressed with 
light pressure via maternal abdomen 
Type II OI is a lethal form of OI 
characterized by defects in collagen 
synthesis. Collagen is a heterotrimer of 
two alpha 1 and one alpha 2 chains 
which form an alpha helix.8 This helical 
arrangement requires the presence of 
the (Gly-X-Y) repeat where X and Y are 
proline and hydroxyproline.1 Our 
reported new mutation is a missense 
mutation in the collagen 1A1 gene 
where glycine is replaced by a serine.  
This mutation interferes with Gly-X-Y 
repeats in the triple helical domain of the 
protein encoded by Col1A1 gene. The 
mutation likely interferes with 
appropriate formation of the collagen 
alpha helix. Cysteine and serine 
substitutions of the first position glycine 
have been described most frequently.1 
Over 700 mutations of the COL1A1 
gene have been reported to the Human 
Collagen Mutation database 
(http://www.le.ac.uk/ge/collagen/). 
Overall, this mutation placed the infant 
in the type II spectrum of OI. 
Ultrasonographic algorithms for 
diagnosis of skeletal dyscrasias have 
been described.9 As part of this 
diagnosis, femur length is considered 
the best indicator for detection of 
skeletal dyscrasias antenatally.5,10 In 
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determining poor neonatal survival, the 
ratio of femur length to abdominal 
circumference has been reliably 
predictive.2,3 In our case the initial 
FL:AC ratio at 19 weeks was 0.13, 
though the rest of the long bones were 
not severely shortened and the head 
circumference (HC) and TC were 
normal at the 30th and 41st percentiles 
respectively. Over the course of the 
pregnancy, the HC remained in the 
normal range, as was the TC, until 31 
4/7 weeks, at which time the TC was at 
the 5th percentile. It is thought that 
death is usually caused by a narrowed 
thorax, which results in impaired lung 
development.11 In our case, the neonate 
was able to breathe spontaneously at 
birth, requiring minimal respiratory 
support until day of life 19, which is 
consistent with the prenatal thoracic 
findings of normal TC until 31 weeks 
gestation. The early and constant 
finding of a FL:AC ratio of <0.16, was 
the main prenatal finding which helped 
predict the lethality of this condition in a 
timely manner. This would support that if 
the thorax has normal growth until the 
3rd trimester, the respiratory failure is 
less severe with relatively prolonged 
neonatal course.  
This case highlights a new mutation of 
COL1A1 gene associated with lethal OI. 
It also confirms the reliability of the 
FL:AC ratio at mid-gestation in 
predicting lethality, as well as the 
importance of thoracic examinations in 
predicting the neonatal course.  
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